Neurorehabilitation

Neurorehabilitation Devices Market to Almost Double by 2026, Surpassing US$ 2.3 Billion

Retrieved on: 
Thursday, September 8, 2022
Lists of diseases, Central nervous system, Neurorehabilitation, Multiple sclerosis, Robotics, Incidence, Maintenance, BCI, DNA, Investment, NEW, Research report, Prevalence, Stroke, CAGR, Parkinson's disease, Spinal cord, Cerebral palsy, Acquisition, Growth, Black Rock, Retail, Medical device, Pharmaceutical industry

NEW YORK, Sept. 8, 2022 /PRNewswire/ -- The global neurorehabilitation devices market is slated to expand at an impressive CAGR of 15% during the forecast period from 2022 to 2026. At the moment, the global neurorehabilitation devices market is valued at US$ 1.3 billion and is predicted to attain a market valuation of US$ 2.3 billion by 2026.

Key Points: 
  • Fact.MR's report on the neurorehabilitation devices market gives insights on significant trends including opportunities, challenges, and competitive scenarios driving the market.
  • At the moment, the global neurorehabilitation devices market is valued at US$ 1.3 billion and is predicted to attain a market valuation of US$ 2.3 billion by 2026 .
  • Neurorehabilitation devices target to improve a patient's brain function by curing the harm caused by a neurological disease or injury.
  • Based on product type, brain computer interface segment accounts for almost one-fourth of the global market share for the neurorehabilitation devices market.

Global Neurotechnology Market Report 2022: Products will be $8.4 Billion in 2018 and will Reach $13.3 Billion in 2022 - Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, August 8, 2022
Health, General Health, Carbon, Huber loss, Migraine, Parkinson's disease, Depression, Lists of diseases, Deafness, Nanotechnology, Chronic pain, Obesity, Industry, Sleep, Population, Technology, Growth, Neurorehabilitation, Market, Prevalence, Research, Pain, Quality of life, Patient, Stroke, Severe cognitive impairment, Ageing, Neurotechnology, Awareness, Epilepsy, Interface (computing), Neuroscience, MEMS, Hearing loss, Electrode, Science, Dyslexia, Autism, Physician, Hypertension, Metal, Life expectancy, Urinary incontinence, Degenerative disease, Kool-Aid, Pharmaceutical industry, Marketing, Medical device

Overall worldwide market for neurotechnology products will be $8.4 billion in 2018 and will reach $13.3 billion in 2022.

Key Points: 
  • Overall worldwide market for neurotechnology products will be $8.4 billion in 2018 and will reach $13.3 billion in 2022.
  • This newly updated market research report is the most comprehensive and up-to-date publication available covering the neurotechnology industry.
  • The report takes an in-depth look at the technology, markets, competitors, and growth rates in four key segments of the neurotechnology industry in the years 2022 through 2026.
  • The report covers in detail the key public companies and the most significant emerging and more established non-public firms in the industry.

Constant Therapy Announces Publication of Study Demonstrating Improved Outcomes for Post-Stroke Patients Using Its Digital Speech, Language, and Cognitive Therapy

Retrieved on: 
Wednesday, July 20, 2022
Treatment, University of Pittsburgh School of Health and Rehabilitation Sciences, GLOBE, Cognitive disorder, Lists of diseases, Digital, Traumatic brain injury, Research, Boston University, Neurorehabilitation, Linearity, Medicine, Dementia, LMMS, Constant, Post-stroke depression, CEO, James, Language, Journal of Medical Internet Research, Journal, Speech, Anatomical pathology, Technology, Transport, Patient, LinkedIn, Boston University College of Health and Rehabilitation Sciences (Sargent College), TBI, Stroke, Efficiency, Rehabilitation, Medical imaging, Pharmaceutical industry, Aphasia, Health

The study, conducted by a Boston University Research Team led by Dr. Swathi Kiran, analyzed data from Constant Therapys mobile speech, language, and cognitive therapy program.

Key Points: 
  • The study, conducted by a Boston University Research Team led by Dr. Swathi Kiran, analyzed data from Constant Therapys mobile speech, language, and cognitive therapy program.
  • The researchers analyzed anonymized data from 2,249 post-stroke survivors who used Constant Therapy between 2016 and 2019.
  • For each patient, weekly therapy dosage was calculated based on the median number of days per week (1, 2, 3, 4, or 5+) of Constant Therapy usage over the 10-week therapy period.
  • These study results demonstrate the benefits of providing digital therapy to patients at home so they can get the optimal dose of therapy to regain their cognitive skills.

Insights on the Neurorehabilitation Global Market to 2030 - Opportunity Analysis and Industry Forecasts - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 8, 2022
Managed Care, Health, Prevalence, Industry, Interface (computing), Growth, Nervous system, Telerehabilitation, Stroke, Awareness, Rancho Los Amigos National Rehabilitation Center, Multiple sclerosis, Neurorehabilitation, Cerebral palsy, Neuro, Hospital, Population, Disorder, Parkinson's disease, Lists of diseases, CAGR, Medical device

The global neurorehabilitation market was valued at $ 1,097.69 million in 2020 and is projected to reach $ 2,45million by 2030 registering a CAGR of 8.3% from 2021 to 2030.

Key Points: 
  • The global neurorehabilitation market was valued at $ 1,097.69 million in 2020 and is projected to reach $ 2,45million by 2030 registering a CAGR of 8.3% from 2021 to 2030.
  • However, high cost of neurorehabilitation devices and lack of adequate skilled professionals to operate neurorehabilitation devices and perform neurorehabilitation therapies in the healthcare industry hamper growth of the market.
  • The global neurorehabilitation market is segmented on the basis of type, application, end user, and region to provide a detailed assessment of the market.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of neurorehabilitation used across the globe.

Neurorehabilitation Devices Markets, 2026 - Neuro-Robotic Devices & Stroke; the Lucrative Segments

Retrieved on: 
Monday, January 24, 2022
CAGR, Patient, Technology, Robotics, Stroke, Rehabilitation, Cerebral palsy, Incidence, Brain–computer interface, Science and technology in Asia, COVID-19, Interface (computing), Population, Ageing, Growth, Spinal cord injury, Spine, Brain damage, Neurorehabilitation, Neuroscience, Communication, Lists of diseases, Brain, Awareness, Pharmaceutical industry, Medical imaging, Pet, Video game

Neurorehabilitation devices are witnessing extensive use in clinical settings, cognitive care, healthcare centers and research institutes.

Key Points: 
  • Neurorehabilitation devices are witnessing extensive use in clinical settings, cognitive care, healthcare centers and research institutes.
  • This segment currently accounts for a 25% share of the global Neurorehabilitation Devices market.
  • The market growth is facilitated by rising awareness about advantages of neurorehabilitation devices coupled with presence of a robust healthcare infrastructure.
  • The neurorehabilitation wearable devices segment is poised to maintain its positive trajectory due to availability of innovative options offering better alternatives to traditional neurorehabilitation approaches.

Neurorehabilitation Devices Industry Analysis and 95 Competitor Profiles, 2022-2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 21, 2022
Mental Health, Technology, Medical Devices, Other Technology, Other Health, Biotechnology, Hardware, Electronic Design Automation, Health, Data Management, CAGR, Patient, Technology, Robotics, Stroke, Rehabilitation, Cerebral palsy, Incidence, Brain–computer interface, Science and technology in Asia, COVID-19, Interface (computing), Population, Ageing, Growth, Spinal cord injury, Spine, Brain damage, Neurorehabilitation, Neuroscience, Communication, Lists of diseases, Brain, Awareness, Pharmaceutical industry, Medical imaging, Pet, Video game

Neurorehabilitation devices are witnessing extensive use in clinical settings, cognitive care, healthcare centers and research institutes.

Key Points: 
  • Neurorehabilitation devices are witnessing extensive use in clinical settings, cognitive care, healthcare centers and research institutes.
  • This segment currently accounts for a 25% share of the global Neurorehabilitation Devices market.
  • The market growth is facilitated by rising awareness about advantages of neurorehabilitation devices coupled with presence of a robust healthcare infrastructure.
  • The neurorehabilitation wearable devices segment is poised to maintain its positive trajectory due to availability of innovative options offering better alternatives to traditional neurorehabilitation approaches.

SiYi Intelligence Revealed Its Latest Soft Exoskeleton Hand Rehabilitation Robotic System at MEDICA 2021, filling the gap in the European Neurorehabilitation market

Retrieved on: 
Tuesday, November 23, 2021
Patient, Exhibition, Rehabilitation, Printing, Hospital, Neurorehabilitation, Household, US, Research, Clinical, MEDICA, US FDA, Intelligence, Certification, Healthcare, Medical device

According to research, rehabilitation robots in the European and American markets are dominated by traditional rigid large-scale medical equipment.

Key Points: 
  • According to research, rehabilitation robots in the European and American markets are dominated by traditional rigid large-scale medical equipment.
  • As the world's leading high-tech company to apply soft robotics technology to rehabilitation equipment, SiYi Intelligence has developed a product matrix for Clinical and household products to fill this gap.
  • At present, the main products are EasyWalk", SYREBOTM Hand rehabilitation Robotic gloves series", etc.
  • SiYi Intelligence has applied for more than 40 patents, participated in a number of national key research and development.

Study: Brain Training Can Address Persistent Issues from Traumatic Brain Injuries

Retrieved on: 
Tuesday, September 14, 2021
Library, SAN, Injury, Traumatic brain injury, Patient, Attention, Government budget balance, Brain, Brain damage, TBI, Neurorehabilitation, Posit Science Corporation, GLOBE, Male, Cognition, Cognitive deficit, Pharmaceutical industry, Medical imaging

The researchers used the cognitive training exercises found in the brain fitness app BrainHQ from Posit Science .

Key Points: 
  • The researchers used the cognitive training exercises found in the brain fitness app BrainHQ from Posit Science .
  • In their report in the journal Neurorehabilitation , the researchers note that approximately 5.3 million Americans currently live with a chronic disability as a result of a Traumatic Brain Injury (TBI).
  • They had symptoms that had persisted for more than 8 years, on average, since their brain injuries.
  • In addition, the brain training participants showed improvements in standard subjective measures of their own cognitive abilities in everyday tasks.